Klingman & Associates’s GE HealthCare GEHC Stock Holding History

Klingman & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$242K	Buy	3,706 +421	+13%	+$28.5K	0.01%	373
2026 Q2	$210K	Sell	3,285 -700	-18%	-$46K	0.01%	335
2026 Q1	$284K	Buy	3,985 +253	+7%	+$20K	0.01%	270
2025 Q4	$306K	Buy	3,732 +98	+3%	+$7.64K	0.01%	252
2025 Q3	$273K	Buy	3,634 +139	+4%	+$10.4K	0.01%	270
2025 Q2	$259K	Sell	3,495 -1,716	-33%	-$119K	0.01%	269
2025 Q1	$421K	Buy	5,211 +23	+0.4%	+$1.98K	0.03%	177
2024 Q4	$406K	Sell	5,188 -2,056	-28%	-$175K	0.02%	175
2024 Q3	$680K	Buy	7,244 +3,788	+110%	+$318K	0.04%	133
2024 Q2	$269K	Buy	3,456 +559	+19%	+$45.6K	0.02%	206
2024 Q1	$263K	Buy	2,897 +38	+1%	+$3.16K	0.02%	204
2023 Q4	$221K	Buy	+2,859	New	+$200K	0.02%	216
2023 Q3	–	Sell	-2,889	Closed	-$235K	–	224
2023 Q2	$235K	Buy	2,889 +27	+0.9%	+$2.16K	0.02%	194
2023 Q1	$235K	Buy	+2,862	New	+$204K	0.02%	180

Other funds holding GEHC

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Auto-Owners Insurance Lansing, Michigan $3.2B AUM 21.13% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Klingman & Associates's GEHC Position: Q3 2026 in Review

Klingman & Associates increased its GE HealthCare (GEHC) stake by 13% in Q3 2026, buying an estimated $28.5K and bringing the position to 3,706 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #373.

Klingman & Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $680K in Q3 2024. 287 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

Klingman & Associates held 3,706 shares of GE HealthCare worth $242K as of Q3 2026.
Klingman & Associates bought 421 GE HealthCare shares in Q3 2026, an estimated $28.5K.
GE HealthCare made up 0.01% of Klingman & Associates's portfolio in Q3 2026, its #373 holding.
Klingman & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Klingman & Associates's GE HealthCare position peaked at $680K in Q3 2024.
287 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.